Inventor · disambiguated record
Martin Schäfer
Also filed as: SCHAFER MARTIN · Schäfer Martin
6 granted patents·8 pending applications·65 citations·filing 2008–2024
85Inventor score
Top patents by PatentIndex Score
14 records- 0196US11951190B2Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2021·Granted Apr 9, 2024·4 cites·62 claims
- 0296US11931430B2Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2020·Granted Mar 19, 2024·5 cites·15 claims
- 0396US11045564B2Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2019·Granted Jun 29, 2021·10 cites·15 claims
- 0496US10398791B2Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2018·Granted Sep 3, 2019·22 cites·30 claims
- 0594US10471160B2Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2018·Granted Nov 12, 2019·16 cites·28 claims
- 0691US10016519B218F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2017·Granted Jul 10, 2018·8 cites·18 claims
- 0790US2024382631A1Use of labeled inhibitors of prostate specific membrane antigen (psma), as agents for the treatment of prostate cancerNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0889US2024350680A1Labeled inhibitors of prostate specific membrane antigen (psma) as agents for the treatment of prostate cancerNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0974US2025057993A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancersUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 1071US2019336622A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2019·Application pending·0 cites
- 1162US2016228587A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2016·Application pending·0 cites
- 1261US2021393809A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancersUNIV HEIDELBERT·Filed 2019·Application pending·0 cites
- 1355US2009130020A1Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcoholsLEHMANN LUTZ·Filed 2008·Application pending·0 cites
- 1448US2022324898A1Prostate specific membrane antigen (psma) ligands comprising an amylase cleavable linkerDEUTSCHES KREBSFORSCH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Schäfer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →